ADCs

Lonza's Continuing Investment in High Potency API: An Interview with Christian Dowdeswell

Content Type: Whitepaper/Executive Summary

Authors: Christian Dowdeswell

Publish Date: 9/18/2020

Highly potent compounds are growing at double the rate of other small molecule active ingredients due to the industries investment in increasingly targeted and more effective therapies. The increasing demand for highly potent compounds is concentrated among three therapeutic areas chief among these is oncology, along with diabetes and autoimmune diseases. To learn more, read the interview.